davide angeletti - Infectious Diseases

Author Information

Davide Angeletti is affiliated with the Laboratory of Viral Diseases at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health in Bethesda, MD. His research primarily focuses on infectious diseases, with particular emphasis on viral infections and immune responses.

Research Contributions

Davide Angeletti has made significant contributions to the field of infectious diseases through his research on immune responses to viral infections. His work includes studies on the development of T and B cells during viral infections, particularly influenza and SARS-CoV-2. His research has explored the dynamics of antigen-specific B cells, the role of cDC1 cells in mucosal protection, and the optimization of virus-specific B cell responses. Angeletti's studies have provided insights into the immune mechanisms that underpin protection against viral pathogens, which are crucial for the development of effective vaccines and therapeutic strategies.

Aliases

There are no aliases listed for Davide Angeletti.

Publication and Citation Metrics

Metric	Value
Total Citation Count	1847
h-index	20
Total Paper Count	50

Publications:

ADP-ribosylating adjuvant reveals plasticity in cDC1 cells that drive mucosal Th17 cell development and protection against influenza virus infection.

DOI: 10.1038/s41385-022-00510-1

Year: 2022

Development of Tbet- and CD11c-expressing B cells in a viral infection requires T follicular helper cells outside of germinal centers.

DOI: 10.1016/j.immuni.2022.01.002

Year: 2022

Single-cell BCR and transcriptome analysis after influenza infection reveals spatiotemporal dynamics of antigen-specific B cells.

DOI: 10.1016/j.celrep.2021.109286

Year: 2021

Limited access to antigen drives generation of early B cell memory while restraining the plasmablast response.

DOI: 10.1016/j.immuni.2021.08.017

Year: 2021

ADP-ribosylating adjuvant reveals plasticity in cDC1 cells that drive mucosal Th17 development and protection against influenza virus infection

DOI: 10.21203/RS.3.RS-801483/V1

Year: 2021

Temporal dynamics of persistent germinal centers and memory B cell differentiation following respiratory virus infection.

DOI: 10.1016/j.celrep.2021.109961

Year: 2021

Correction: Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders

DOI: 10.1371/journal.pone.0258401

Year: 2021

Know your enemy or find your friend?—Induction of IgA at mucosal surfaces

DOI: 10.1111/imr.13014

Year: 2021

CD4+ follicular regulatory T cells optimize the influenza virus–specific B cell response

DOI: 10.1084/jem.20200547

Year: 2021

Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders

DOI: 10.1371/journal.pone.0241104

Year: 2020

What Research is Being Done on Dengue Hemorrhagic Fever?

How Does a PCR Test Work?

What role does global travel play in the spread of infectious diseases?

What Role Do Metabolic Pathways Play in Antibiotic Resistance?

What is Chlamydia?

What are Host-Pathogen Interactions?

What role does environmental cleanliness play?

What Future Directions is the NIH Taking in Infectious Disease Research?

When to Use Decongestants?

How Do Pathogens Utilize Fatty Acid Biosynthesis?

Partnered Content Networks

Relevant Topics